+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Fibromyalgia Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 276 Pages
  • Global
From
From
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
Renal Anemia Therapeutics Market 2025-2029 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 210 Pages
  • Global
From
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Non-Opioid Pain Patch Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Patch Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Antibiotics Market Report 2025 - Product Thumbnail Image

Antibiotics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • February 2026
  • 187 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Loading Indicator